Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2007
10/04/2007WO2007110977A1 Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical
10/04/2007WO2007110878A1 Sustained release pharmaceutical composition on the basis of a release system comprising an acid-soluble polymer and a ph-dependent polymer.
10/04/2007WO2007110875A1 Antibiotic compositions of modified release and process of production thereof
10/04/2007WO2007110778A2 Mucosal bioadhesive slow release carrier for delivering active principles
10/04/2007WO2007110753A2 Extended release dosage forms of metoprolol
10/04/2007WO2007110356A1 Spray composition for topical use for treating and/or preventing herpes simplex labial infections
10/04/2007WO2007110226A1 Stable oral pharmaceutical composition containing thyroid hormone receptor agonists
10/04/2007WO2007110152A2 Polylactide nanoparticles
10/04/2007WO2007109893A1 Plant extracts and uses thereof
10/04/2007WO2007109892A1 Plant extracts and uses thereof in filter systems
10/04/2007WO2007093642A3 Microparticulate pharmaceutical forms resistant to immediate release of the active principle in the presence of alcohol
10/04/2007WO2007093168A3 Rapid release irbesartan-containing pharmaceutical composition
10/04/2007WO2007092642A3 Polymer formulations of cetp inhibitors
10/04/2007WO2007090881A3 Modified release formulation
10/04/2007WO2007088343A8 Granular material comprising water- insoluble inorganic phosphate binders
10/04/2007WO2007083164A3 Liquid electrostatic spray composition
10/04/2007WO2007082726A3 Flowable leuprolide-containing composition for treating inflammation-mediated neurodegenerative diseases
10/04/2007WO2007077551A3 Device and method for treating the anal sphincter
10/04/2007WO2007076144A3 Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
10/04/2007WO2007072065A3 Silicone composition
10/04/2007WO2007067964B1 Mucosal delivery of stabilized formulations of exendin
10/04/2007WO2007058935A3 Ophthalmic composition for dry eye therapy
10/04/2007WO2007058462A9 Method for preparing sustained-release microparticles comprising sucrose acetate isobutyrate
10/04/2007WO2007052152A3 Sertraline oral concentrate
10/04/2007WO2007049137A3 Canola extracts containing high levels of sinapic acid
10/04/2007WO2007044251A3 Pharmaceutical compositions
10/04/2007WO2007039201A3 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis
10/04/2007WO2007027565A3 Argatroban formulation comprising an acid as solubilizer
10/04/2007WO2007025261A3 Non-irritating solvent-borne polymeric coatings for application to the skin
10/04/2007WO2007021844A3 Coated substrate with properties of keratinous tissue
10/04/2007WO2007014003A3 Systems and methods for delivery of a therapeutic agent
10/04/2007WO2007002465A3 Stabilizing alkylglycoside compositions and methods thereof
10/04/2007WO2006105154A3 Method and system for controllably releasing solutions
10/04/2007WO2006099258A8 Tigecycline compositions and methods of preparation
10/04/2007WO2006004940A3 Spinal disc nucleus pulposus implant
10/04/2007WO2005016239A3 Molecules enhancing dermal delivery of influenza vaccines
10/04/2007US20070233051 Drug delivery systems and methods
10/04/2007US20070233050 Medication administration and management system and method
10/04/2007US20070233049 Medication administration and management system and method
10/04/2007US20070233048 Combination cartridge and device for electrokinetic delivery of medicament to a treatment site
10/04/2007US20070233036 Eustachian Tube Device and Method
10/04/2007US20070232904 Application of Hyaluronic Acid to Sentinel Lymph Node Identification
10/04/2007US20070232667 Methods for Treating Hyperlipidemia With Intermediate Release Nicotinic Acid Compositions Having Unique Biopharmaceutical Characteristics
10/04/2007US20070232629 Adhesive Patch
10/04/2007US20070232561 Pharmaceutical compositions for promoting wound healing
10/04/2007US20070232536 Pharmaceutical compositions containing plasma protein
10/04/2007US20070232529 Active agent delivery systems and methods for protecting and administering active agents
10/04/2007US20070232528 Formulation comprising histone deacetylase inhibitors
10/04/2007US20070232524 Use of N-(5-chlorosalicyloyl)8-aminocaprylic acid (5-CNAC), N-10-[2-hydroxybenzoyl]aminodecanoic acid (SNAD) or N-(8-[2-hydroxybenzoyl]amino)caprylic acid (SNAC), or their disodium salts to improve bioavailability
10/04/2007US20070231591 Adhesive Material
10/04/2007US20070231418 Emulsion containing a plant extract, method for producing said emulsion and for obtaining said plant extract
10/04/2007US20070231408 Colloidal metal compositions and methods
10/04/2007US20070231400 Triggered release from proteinoid microspheres
10/04/2007US20070231399 Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
10/04/2007US20070231398 Antisolvent Emulsion Solidification Process
10/04/2007US20070231397 Method for Producing Coated Drugs Having a Stable Profile for the Release of Active Ingredients
10/04/2007US20070231396 Medication spray formulation
10/04/2007US20070231395 Solid Pharmaceutical Preparation for Dialysis
10/04/2007US20070231394 Agent for Removing Circulatory Dysfunction Factor
10/04/2007US20070231393 System and Device for Magnetic Drug Targeting with Magnetic Drug Carrier Particles
10/04/2007US20070231392 CHEMICALLY MODIFIED POLYCATION POLYMER FOR siRNA DELIVERY
10/04/2007US20070231391 Anti-microbial and hydrophilic article and methods for manufacturing the same
10/04/2007US20070231390 Formulations including hygroscopic compounds
10/04/2007US20070231389 Non-homogenous dosage form coatings
10/04/2007US20070231388 Novel Pharmaceutical Dosage Form and Manufacturing Process
10/04/2007US20070231387 Film-coated solid dosage forms
10/04/2007US20070231386 Novel Pharmaceutical Formulation Containing a Biguanide and an Agiotension Antagonist
10/04/2007US20070231385 Controlled Release Pharmaceutical Composition and a Process for Preparing the Same
10/04/2007US20070231384 Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions
10/04/2007US20070231383 Cr3O(carboxylate)6(ligand)3]+ (3)wherein carboxylate is a C2-C5 alkyl carboxylate and wherein the ligand is a ligand that (i) renders the chromium complex insoluble or only slightly soluble in water and (ii) is acid labile; diabetes
10/04/2007US20070231382 Pharmaceutical composition
10/04/2007US20070231381 Controlled-release dosage forms comprising zolpidem or a salt thereof
10/04/2007US20070231380 Diagnosis and prognosis of wound infection by measurement of a phospholipase a2 in wound fluid
10/04/2007US20070231379 Liposome-entrapped topoisomerase inhibitors
10/04/2007US20070231378 Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
10/04/2007US20070231377 Compositions for promoting hair growth
10/04/2007US20070231376 Methods and compositions for modulating axonal outgrowth of central nervous system neurons
10/04/2007US20070231375 Liposome combination and the use thereof
10/04/2007US20070231374 Composition Comprising Ether Lipid
10/04/2007US20070231373 Transdermal Steriod for Formulation
10/04/2007US20070231372 Tissue Sealant
10/04/2007US20070231368 Pharmaceutical formulations of 6-11 bicyclic macrolide derivative known as edp-182 and methods for preparation thereof
10/04/2007US20070231367 Bitterness-masking particulate jelly beverage
10/04/2007US20070231364 Biocompatible Membrane and Process for Producing the Same
10/04/2007US20070231360 Neural conduit agent dissemination
10/04/2007US20070231353 Compositons and methods for maintaining eyelid hygiene
10/04/2007US20070231352 Mucoadhesive thermoresponsive medicament-carrier composition
10/04/2007US20070231350 immunogenically active component of West Nile virus or plasmid DNA which is pCBWN, an adjuvant such as a metabolizable oil, and a pharmacologically acceptable carrier are formulated into an immunizing vaccine for preventing West Nile disease, such as encephalitis in equine
10/04/2007US20070231349 immunogenically active component of West Nile virus or plasmid DNA which is pCBWN, an adjuvant such as a metabolizable oil, and a pharmacologically acceptable carrier are formulated into an immunizing vaccine for preventing West Nile disease, such as encephalitis in equine
10/04/2007US20070231294 Ophthalmic Compositions Containing A Synergistic Combination Of Three Polymers
10/04/2007US20070231273 Method for Decreasing Blood Glucose Levels
10/04/2007US20070231272 Process for Preparing Inhalable Powders
10/04/2007US20070231271 Topical composition of biocellulose as gel, spray-aerosol, cream and/or aqueous for the treatment of epithelial lesions
10/04/2007US20070231269 Analgesics
10/04/2007US20070231266 Diagnosis of macrophage mediated disease
10/04/2007US20070228588 Apparatus for producing particles, emulsifier holding member, method for producing particles, and method for producing molecular membrane
10/04/2007DE10262176B4 Verfahren zur Herstellung von antibiotisch beschichteten porösen Körpern sowie Verwendung Process for the preparation of antibiotically coated porous bodies as well as use of
10/04/2007DE10227935B4 Verfahren zur Herstellung einer antibiotische Beschichtung von porösen Körpern sowie Verwendung A process for preparing a antibiotic coating of porous bodies, and using
10/04/2007DE102006015544A1 Topisch zu applizierende Zusammensetzung Topical application composition
10/04/2007CA2681795A1 Synthetic lipid rafts and methods of use
1 ... 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 ... 2991